Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
08 Gennaio 2024 - 8:00AM
Disclosure notification from AOC Pharma S.à r.l. – passing 10%
threshold
Regulated informationNazareth (Belgium)/Rotterdam (The
Netherlands), 8 January 2024 – 8AM CET
Disclosure notification from AOC Pharma S.à r.l. –
passing 10% threshold
On 27 December 2023, Fagron received a notification pursuant to
the Belgian law of 2 May 2007 regarding the disclosure of major
shareholdings in listed companies from AOC Pharma S.à r.l., an
entity controlled by the value investor Active Ownership, that its
shareholding crossed the 10% disclosure threshold as the result of
the acquisition of voting securities or voting rights on 19
December 2023.
Rafael Padilla, CEO of Fagron: “It is very
pleasing to see Active Ownership has continued to increase its
position in Fagron having initially entered the stock in October
2022. Klaus Röhrig also joined the Fagron Board in May 2023 as
Active Ownership’s representative, and we have developed an
excellent working relationship benefitting from their broad
experience and expertise. Fagron is the global leader in the niche
pharmaceutical compounding market, and we remain committed to
creating value for all our stakeholders over the coming years.”
Klaus Röhrig, founding partner of Active Ownership and
member of Fagron’s Board of Directors: "By increasing our
stake to more than 10 per cent of the shares, we are expressing our
confidence in Fagron’s future development and our trust in its
outstanding management team. The company perfectly matches our
investment strategy: not only is Fagron a leading player in robust
niche markets with promising growth prospects, it also generates a
strong and resilient operating cash flow and has an excellent
reputation as a reliable business partner. We look forward to
continuing our partnership with the management and Board of
Directors and supporting the company in the long term with our
expertise in the healthcare sector and our network."
Notification AOC Pharma S.à r.l.
- The notification is made by a ‘parent undertaking or a
controlling person’.
- On 19 December 2023, AOC Pharma S.à r.l. held a total of
8,102,492 voting rights. Based on the denominator of 73,228,904
(total number of voting rights), this corresponds with 11.06% of
the total number of voting rights.
- AOC Pharma S.à r.l. is controlled by Active Ownership Fund
SICAV-FIS SCS. Active Ownership Capital S.à r.l. is the general
partner of Active Ownership Fund SICAV-FIS SCS. On 1 October 2019,
an agreement was concluded by Active Ownership Fund SICAV-FIS SCS
regarding the appointment of Active Ownership Corporation S.à r.l.
as AIFM (alternative investment fund manager) for Active Ownership
Fund SICAV-FIS SCS. Pursuant to this agreement and appointment
Active Ownership Corporation S.à r.l will exercise the voting
rights with respect to shares held by Active Ownership Fund
SICAV-FIS SCS. Active Ownership Corporation S.à r.l. and Active
Ownership Capital S.à r.l. are both jointly controlled by two
shareholders, Active Ownership Advisors GmbH and Active Ownership
Investments Ltd. Active Ownership Advisors GmbH is controlled by
Florian Schuhbauer. Active Ownership Investments Ltd. is controlled
by Active Ownership LP, which is controlled by Active Ownership
Management Ltd, which is controlled by Klaus Röhrig.
- The notification of Active Ownership Corporation S.à r.l. can
be viewed via this link.
Further informationKaren BergTel. +31 6 53 44
91 99karen.berg@fagron.com
Press contact Active OwnershipMarie HuygheTel.
+32 474 97 39 36mh@whyte.be
About FagronFagron is a leading global company
active in pharmaceutical compounding, focusing on delivering
personalized medicine to hospitals, pharmacies, clinics, and
patients in more than 30 countries around the world.
Belgian company Fagron NV has its registered office in Nazareth
and is listed on Euronext Brussels and Euronext Amsterdam under the
ticker symbol ‘FAGR’. Fagron’s operational activities are managed
by the Dutch company Fagron BV, which is headquartered in
Rotterdam.
About Active Ownership Active Ownership is an
independent, partner-managed investment firm operating primarily in
Continental Europe and Scandinavia. From offices in Frankfurt,
Vienna, Luxembourg and Stockholm, its team performs deep
fundamental research on companies where there is an opportunity for
sustainable value creation. Investing with a long-term horizon,
Active Ownership works constructively with boards and management to
allow companies to reach their full potential. Active Ownership’s
investor base consists primarily of foundations, family offices and
other institutional investors. www.activeownership.lu
In the event of differences between the English translation and
the Dutch original of this press release, the latter prevails.
- Disclosure notification from AOC Pharma S.à r.l. – passing 10%
threshold
Grafico Azioni Fagron NV (EU:FAGR)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Fagron NV (EU:FAGR)
Storico
Da Nov 2023 a Nov 2024
